Search
for
Sort by
Research 31–60 of 134
- Tribal Colleges and University Project - Native American Internships
- Expert Opinion: Migraine, Psychiatric Comorbidities, and Treatment
- Off Label Medication and Use of Unapproved Drugs
- A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania
- Scleroderma and L-tryptophan: A possible explanation of the eosinophilia-myalgia syndrome
- Adverse cutaneous effects of psychotropic medications
- Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation
- 31-Year-Old Woman With Alopecia
- Obesity and the skin: Skin physiology and skin manifestations of obesity
- Hair Loss in Women
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- TOXIC EPIDERMAL NECROLYSIS
- Psychocutaneous disease
- Trichotillomania: Clinical Aspects and Treatment Strategies *
- Topically used herbal products for the treatment of hair loss: preclinical and clinical studies
- Psychodermatology
- Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines
- Pediatric Psychocutaneous Disorders
- Alopecia associated with quetiapine
- Anticonvulsant-Induced Cutaneous Reactions
- Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder
- Focal and Generalized Alopecia
- A machine learning and network framework to discover new indications for small molecules
- Psychotropic Medications and the Skin
- Medication Repurposing: New Uses for Old Drugs
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- Update on psychodermatological disorders
- Women's Dermatologic Diseases, Health Care Delivery, and Socioeconomic Barriers
- Cutaneous Reactions to Drugs
- RETIRED: Managing Menopause Chapter 8 Sexuality and Menopause